A	O
Novel	O
Regulatory	O
Mechanism	O
of	O
Type	O
II	O
Collagen	O
Expression	O
via	O
a	O
SOX9	O
-	O
dependent	O
Enhancer	O
in	O
Intron	O
6	O
.	O


Type	O
II	O
collagen	O
alpha1	O
is	O
specific	O
for	O
cartilaginous	O
tissues	O
,	O
and	O
mutations	O
in	O
its	O
gene	O
are	O
associated	O
with	O
skeletal	O
diseases	O
.	O


Its	O
expression	O
has	O
been	O
shown	O
to	O
be	O
dependent	O
on	O
SOX9	O
,	O
a	O
master	O
transcription	O
factor	O
required	O
for	O
chondrogenesis	O
that	O
binds	O
to	O
an	O
enhancer	O
region	O
in	O
intron	O
1	O
.	O


However	O
,	O
ChIP	O
sequencing	O
revealed	O
that	O
SOX9	O
does	O
not	O
strongly	O
bind	O
to	O
intron	O
1	O
,	O
but	O
rather	O
it	O
binds	O
to	O
intron	O
6	O
and	O
a	O
site	O
30	O
kb	O
upstream	O
of	O
the	O
transcription	O
start	O
site	O
.	O


Here	O
,	O
we	O
aimed	O
to	O
determine	O
the	O
role	O
of	O
the	O
novel	O
SOX9	O
-	O
binding	O
site	O
in	O
intron	O
6	O
.	O


We	O
prepared	O
reporter	O
constructs	O
that	O
contain	O
a	O
Col2a1	O
promoter	O
,	O
intron	O
1	O
with	O
or	O
without	O
intron	O
6	O
,	O
and	O
the	O
luciferase	O
gene	O
.	O


Although	O
the	O
reporter	O
constructs	O
were	O
not	O
activated	O
by	O
SOX9	O
alone	O
,	O
the	O
construct	O
that	O
contained	O
both	O
introns	O
1	O
and	O
6	O
was	O
activated	O
5	O
-	O
10	O
-	O
fold	O
by	O
the	O
SOX9	O
/	O
SOX5	O
or	O
the	O
SOX9	O
/	O
SOX6	O
combination	O
in	O
transient	O
-	O
transfection	O
assays	O
in	O
293T	O
cells	O
.	O


This	O
enhancement	O
was	O
also	O
observed	O
in	O
rat	O
chondrosarcoma	O
cells	O
that	O
stably	O
expressed	O
the	O
construct	O
.	O


CRISPR	O
/	O
Cas9	O
-	O
induced	O
deletion	O
of	O
intron	O
6	O
in	O
RCS	O
cells	O
revealed	O
that	O
a	O
10	O
-	O
bp	O
region	O
of	O
intron	O
6	O
is	O
necessary	O
both	O
for	O
Col2a1	O
expression	O
and	O
SOX9	O
binding	O
.	O


Furthermore	O
,	O
SOX9	O
,	O
but	O
not	O
SOX5	O
,	O
binds	O
to	O
this	O
region	O
as	O
demonstrated	O
in	O
an	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
although	O
both	O
SOX9	O
and	O
SOX5	O
bind	O
to	O
a	O
larger	O
325	O
-	O
bp	O
fragment	O
of	O
intron	O
6	O
containing	O
this	O
small	O
sequence	O
.	O


These	O
findings	O
suggest	O
a	O
novel	O
mechanism	O
of	O
action	O
of	O
SOX5	O
/	O
6	O
;	O
namely	O
,	O
the	O
SOX9	O
/	O
5	O
/	O
6	O
combination	O
enhances	O
Col2a1	O
transcription	O
through	O
a	O
novel	O
enhancer	O
in	O
intron	O
6	O
together	O
with	O
the	O
enhancer	O
in	O
intron	O
1	O
.	O
